Idiopathic Overactive Bladder clinical trials

Explore recruiting idiopathic overactive bladder clinical trials.

Recruiting idiopathic overactive bladder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Idiopathic Overactive Bladder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An exploratory, prospective, multicenter, randomized, double blind, placebo + sham device controlled, study to assess the safety, usability, and initial efficacy of the ViXe combination for intravesical administration of XEOMIN® in the treatment of female patients with idiopathic overactive bladder (OAB).

Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

Idiopathic Overactive Bladder trials by city

Idiopathic Overactive Bladder in Toronto Idiopathic Overactive Bladder in Vancouver Idiopathic Overactive Bladder in Montreal Idiopathic Overactive Bladder in Calgary Idiopathic Overactive Bladder in Edmonton Idiopathic Overactive Bladder in Ottawa Idiopathic Overactive Bladder in Winnipeg Idiopathic Overactive Bladder in Quebec City Idiopathic Overactive Bladder in Hamilton Idiopathic Overactive Bladder in Kitchener Idiopathic Overactive Bladder in London Idiopathic Overactive Bladder in Halifax Idiopathic Overactive Bladder in New York Idiopathic Overactive Bladder in Los Angeles Idiopathic Overactive Bladder in Chicago Idiopathic Overactive Bladder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease